1. E. I. Gusev, A. B. Gekht, G. R. Popov, et al., Parkinson’s Disease. Clinical Aspects, Diagnosis, and Treatment of Neurodegenerative Diseases: Basic and Applied Aspects, M. V. Ugryumov (ed.), Nauka, Moscow (2010), pp. 52–86.
2. I. V. Ekimova, D. V. Plaksina, K. V. Lapshina, et al., “Pathological and compensatory processes in a new model of the preclinical stage of Parkinson’s disease in rats,” Acta Naturae, Spec. Iss., No. 1, 50 (2016).
3. I. V. Ekimova, V. V. Simonova, M. A. Guzeev, et al., “Changes in sleep characteristics in a model of the preclinical stage of Parkinson’s disease in rats based on weakening of the activity of the ubiquitin-proteasome system of the brain,” Zh. Evolyuts. Biokhim. Fiziol., 52, No. 6, 413–422 (2016).
4. S. N. Illarioshkin, “The course of Parkinson’s disease and approaches to the early diagnosis,” in: Parkinson’s Disease and Motor Disorders. Guidelines for Doctors: Proc. 2nd Nat. Congress on Parkinson’s Disease and Motor Disorders, S. N. Illarioshkin and O. S. Levin (eds.), Moscow (2011), pp. 41–47.
5. I. V. Milyukhina, M. N. Karpenko, A. A. Timofeeva, et al., “The role of inflammation and the pathogenesis of Parkinson’s disease,” Nevrol. Zh., 18, No. 3, 51–55 (2013).